Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Antiplatelet therapy in ischemic heart disease / / Stephen D. Wiviott
| Antiplatelet therapy in ischemic heart disease / / Stephen D. Wiviott |
| Autore | Wiviott Stephen D. |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley-Blackwell, , 2009 |
| Descrizione fisica | 1 online resource (311 p.) |
| Disciplina |
616.12306
616.123061 |
| Altri autori (Persone) | WiviottStephen D |
| Collana | American Heart Association Clinical Series |
| Soggetto topico |
Coronary heart disease - Chemotherapy
Blood platelets - Aggregation Coronary heart disease - drug therapy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-4443-0333-3
1-4443-0334-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Preface; Foreword; PART I: Concepts in Platelet Physiology, Function, and Measurement; 1 Platelet physiology and the role of the platelet in ischemic heart disease; 2 Laboratory assessment of platelet function and the effects of antiplatelet agents; PART II: Pharmacology of Oral Antiplatelet Agents; 3 Cyclooxygenase inhibitors; 4 Aspirin response variability and resistance; 5 P2Y[sub(12)] inhibitors: Thienopyridines and direct oral inhibitors; 6 Thienopyridine response variability and resistance; PART III: Pharmacology of Intravenous Antiplatelet Agents
7 Pharmacology of intravenous glycoprotein IIb/IIIa antagonists8 Intravenous P2Y[sub(12)] inhibitors; 9 Antiplatelet effects of thrombin inhibitors and fibrinolytic agents; PART IV: Clinical Use of Antiplatelet Agents in Cardiovascular Disease; 10 Antiplatelet therapy in acute coronary syndrome without ST elevation; 11 Antiplatelet therapy in ST-elevation myocardial infarction; 12 Antiplatelet therapy in chronic coronary artery disease; 13 Antiplatelet therapy in peripheral arterial disease; 14 Clinical use of antiplatelet agents in cardiovascular disease: cerebrovascular diseases PART V: Special Circumstances15 Antiplatelet therapy and coronary bypass surgery: risks and benefits; 16 Management of antiplatelet therapy for non-cardiac surgery; 17 Antiplatelet therapy and coronary stents; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; Author Disclosure Table |
| Record Nr. | UNINA-9910146114903321 |
Wiviott Stephen D.
|
||
| Hoboken, New Jersey : , : Wiley-Blackwell, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiplatelet therapy in ischemic heart disease / / Stephen D. Wiviott
| Antiplatelet therapy in ischemic heart disease / / Stephen D. Wiviott |
| Autore | Wiviott Stephen D. |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley-Blackwell, , 2009 |
| Descrizione fisica | 1 online resource (311 p.) |
| Disciplina |
616.12306
616.123061 |
| Altri autori (Persone) | WiviottStephen D |
| Collana | American Heart Association Clinical Series |
| Soggetto topico |
Coronary heart disease - Chemotherapy
Blood platelets - Aggregation Coronary heart disease - drug therapy |
| ISBN |
1-4443-0333-3
1-4443-0334-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Preface; Foreword; PART I: Concepts in Platelet Physiology, Function, and Measurement; 1 Platelet physiology and the role of the platelet in ischemic heart disease; 2 Laboratory assessment of platelet function and the effects of antiplatelet agents; PART II: Pharmacology of Oral Antiplatelet Agents; 3 Cyclooxygenase inhibitors; 4 Aspirin response variability and resistance; 5 P2Y[sub(12)] inhibitors: Thienopyridines and direct oral inhibitors; 6 Thienopyridine response variability and resistance; PART III: Pharmacology of Intravenous Antiplatelet Agents
7 Pharmacology of intravenous glycoprotein IIb/IIIa antagonists8 Intravenous P2Y[sub(12)] inhibitors; 9 Antiplatelet effects of thrombin inhibitors and fibrinolytic agents; PART IV: Clinical Use of Antiplatelet Agents in Cardiovascular Disease; 10 Antiplatelet therapy in acute coronary syndrome without ST elevation; 11 Antiplatelet therapy in ST-elevation myocardial infarction; 12 Antiplatelet therapy in chronic coronary artery disease; 13 Antiplatelet therapy in peripheral arterial disease; 14 Clinical use of antiplatelet agents in cardiovascular disease: cerebrovascular diseases PART V: Special Circumstances15 Antiplatelet therapy and coronary bypass surgery: risks and benefits; 16 Management of antiplatelet therapy for non-cardiac surgery; 17 Antiplatelet therapy and coronary stents; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; Author Disclosure Table |
| Record Nr. | UNINA-9910830371803321 |
|
Wiviott Stephen D.
|
||
| Hoboken, New Jersey : , : Wiley-Blackwell, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Management of acute coronary syndromes [[electronic resource] /] / Eli V. Gelfand and Christopher P. Cannon
| Management of acute coronary syndromes [[electronic resource] /] / Eli V. Gelfand and Christopher P. Cannon |
| Autore | Gelfand Eli V |
| Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley & Sons, 2009 |
| Descrizione fisica | 1 online resource (242 p.) |
| Disciplina |
616.123
616.12306 |
| Altri autori (Persone) | CannonChristopher P |
| Soggetto topico |
Coronary heart disease
Myocardial infarction |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-12366-1
9786612123665 0-470-74546-0 0-470-74545-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Management of Acute Coronary Syndromes; Contents; List of contributors; Foreword; Chapter 1 Pathophysiology of acute coronary syndromes; Introduction; Formation of atherosclerotic plaque; Plaque instability and the development of ACS; Myocardial ischemia; Thrombus formation; Platelets; Secondary hemostasis; Dynamic obstruction; Progressive mechanical obstruction; Inflammation; Secondary unstable angina; References; Chapter 2 Diagnosis of acute coronary syndrome; Introduction; Definition of myocardial infarction; History; Risk factors; Physical examination; Electrocardiography
The pathophysiologic basis of ST segment changes during ischemiaElectrocardiography in ST-elevation MI and identification of the infarct-related artery; Electrocardiography in unstable angina and NSTEMI; Cardiac biomarkers; Noninvasive imaging; Echocardiography; Myocardial perfusion imaging; Coronary computed tomography; Cardiovascular magnetic resonance imaging; Stress testing for diagnosis of ACS; Overall diagnostic pathway for ACS; References; Chapter 3 Unstable angina and non-ST-elevation myocardial infarction; Introduction; Causes of UA/NSTEMI; Presentation of UA/NSTEMI General strategies in management of UA/NSTEMIRisk stratification of patients with UA/NSTEMI; Initial management of UA/NSTEMI in the emergency department; Pharmacologic treatment of ischemia in UA/NSTEMI; Beta-blockers; Nitrates; Calcium channel blockers; Angiotensin-converting enzyme inhibitors; Morphine; Oxygen; Invasive versus conservative strategy; Antiplatelet therapy in UA/NSTEMI; Aspirin; Clopidogrel; Prasugrel; Glycoprotein IIb/IIIa inhibitors; Anticoagulant therapy in UA/NSTEMI; Unfractionated heparin; Enoxaparin; Direct thrombin inhibitors; Fondaparinux Oral anticoagulation in UA/NSTEMIFibrinolysis in UA/NSTEMI; Early lipid-lowering therapy in patients with UA/NSTEMI; Predischarge noninvasive risk stratification after UA/NSTEMI; Overall management of UA/NSTEMI; References; Chapter 4 ST-segment-elevation myocardial infarction; Introduction; Global treatment goals in STEMI; Prehospital management and triage; Transport decisions; Management prior to reperfusion; Primary reperfusion therapy for STEMI; Fibrinolysis; Combination fibrinolysis; Markers of fibrinolysis effectiveness; Complications of fibrinolysis Primary percutaneous coronary interventionComparison of PCI with fibrinolysis; Timing of primary PCI; PCI following fibrinolytic therapy; Rescue PCI; Facilitated PCI; Routine PCI after successful fibrinolysis; Overall reperfusion strategy; Coronary artery bypass grafting for treatment of STEMI; Adjunctive pharmacologic treatment of STEMI; Antiplatelet agents; Anticoagulation therapy; Other adjunctive therapy; Hospital care following successful reperfusion; References; Chapter 5 Special considerations in acute coronary syndromes; Secondary unstable angina Acute coronary syndrome in patients with diabetes mellitus |
| Record Nr. | UNINA-9910146137703321 |
|
Gelfand Eli V
|
||
| Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley & Sons, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Management of acute coronary syndromes [[electronic resource] /] / Eli V. Gelfand and Christopher P. Cannon
| Management of acute coronary syndromes [[electronic resource] /] / Eli V. Gelfand and Christopher P. Cannon |
| Autore | Gelfand Eli V |
| Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley & Sons, 2009 |
| Descrizione fisica | 1 online resource (242 p.) |
| Disciplina |
616.123
616.12306 |
| Altri autori (Persone) | CannonChristopher P |
| Soggetto topico |
Coronary heart disease
Myocardial infarction |
| ISBN |
1-282-12366-1
9786612123665 0-470-74546-0 0-470-74545-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Management of Acute Coronary Syndromes; Contents; List of contributors; Foreword; Chapter 1 Pathophysiology of acute coronary syndromes; Introduction; Formation of atherosclerotic plaque; Plaque instability and the development of ACS; Myocardial ischemia; Thrombus formation; Platelets; Secondary hemostasis; Dynamic obstruction; Progressive mechanical obstruction; Inflammation; Secondary unstable angina; References; Chapter 2 Diagnosis of acute coronary syndrome; Introduction; Definition of myocardial infarction; History; Risk factors; Physical examination; Electrocardiography
The pathophysiologic basis of ST segment changes during ischemiaElectrocardiography in ST-elevation MI and identification of the infarct-related artery; Electrocardiography in unstable angina and NSTEMI; Cardiac biomarkers; Noninvasive imaging; Echocardiography; Myocardial perfusion imaging; Coronary computed tomography; Cardiovascular magnetic resonance imaging; Stress testing for diagnosis of ACS; Overall diagnostic pathway for ACS; References; Chapter 3 Unstable angina and non-ST-elevation myocardial infarction; Introduction; Causes of UA/NSTEMI; Presentation of UA/NSTEMI General strategies in management of UA/NSTEMIRisk stratification of patients with UA/NSTEMI; Initial management of UA/NSTEMI in the emergency department; Pharmacologic treatment of ischemia in UA/NSTEMI; Beta-blockers; Nitrates; Calcium channel blockers; Angiotensin-converting enzyme inhibitors; Morphine; Oxygen; Invasive versus conservative strategy; Antiplatelet therapy in UA/NSTEMI; Aspirin; Clopidogrel; Prasugrel; Glycoprotein IIb/IIIa inhibitors; Anticoagulant therapy in UA/NSTEMI; Unfractionated heparin; Enoxaparin; Direct thrombin inhibitors; Fondaparinux Oral anticoagulation in UA/NSTEMIFibrinolysis in UA/NSTEMI; Early lipid-lowering therapy in patients with UA/NSTEMI; Predischarge noninvasive risk stratification after UA/NSTEMI; Overall management of UA/NSTEMI; References; Chapter 4 ST-segment-elevation myocardial infarction; Introduction; Global treatment goals in STEMI; Prehospital management and triage; Transport decisions; Management prior to reperfusion; Primary reperfusion therapy for STEMI; Fibrinolysis; Combination fibrinolysis; Markers of fibrinolysis effectiveness; Complications of fibrinolysis Primary percutaneous coronary interventionComparison of PCI with fibrinolysis; Timing of primary PCI; PCI following fibrinolytic therapy; Rescue PCI; Facilitated PCI; Routine PCI after successful fibrinolysis; Overall reperfusion strategy; Coronary artery bypass grafting for treatment of STEMI; Adjunctive pharmacologic treatment of STEMI; Antiplatelet agents; Anticoagulation therapy; Other adjunctive therapy; Hospital care following successful reperfusion; References; Chapter 5 Special considerations in acute coronary syndromes; Secondary unstable angina Acute coronary syndrome in patients with diabetes mellitus |
| Record Nr. | UNINA-9910830080403321 |
|
Gelfand Eli V
|
||
| Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley & Sons, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Management of acute coronary syndromes / / Eli V. Gelfand and Christopher P. Cannon
| Management of acute coronary syndromes / / Eli V. Gelfand and Christopher P. Cannon |
| Autore | Gelfand Eli V |
| Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley & Sons, 2009 |
| Descrizione fisica | 1 online resource (242 p.) |
| Disciplina |
616.123
616.12306 |
| Altri autori (Persone) | CannonChristopher P |
| Soggetto topico |
Coronary heart disease
Myocardial infarction |
| ISBN |
1-282-12366-1
9786612123665 0-470-74546-0 0-470-74545-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Management of Acute Coronary Syndromes; Contents; List of contributors; Foreword; Chapter 1 Pathophysiology of acute coronary syndromes; Introduction; Formation of atherosclerotic plaque; Plaque instability and the development of ACS; Myocardial ischemia; Thrombus formation; Platelets; Secondary hemostasis; Dynamic obstruction; Progressive mechanical obstruction; Inflammation; Secondary unstable angina; References; Chapter 2 Diagnosis of acute coronary syndrome; Introduction; Definition of myocardial infarction; History; Risk factors; Physical examination; Electrocardiography
The pathophysiologic basis of ST segment changes during ischemiaElectrocardiography in ST-elevation MI and identification of the infarct-related artery; Electrocardiography in unstable angina and NSTEMI; Cardiac biomarkers; Noninvasive imaging; Echocardiography; Myocardial perfusion imaging; Coronary computed tomography; Cardiovascular magnetic resonance imaging; Stress testing for diagnosis of ACS; Overall diagnostic pathway for ACS; References; Chapter 3 Unstable angina and non-ST-elevation myocardial infarction; Introduction; Causes of UA/NSTEMI; Presentation of UA/NSTEMI General strategies in management of UA/NSTEMIRisk stratification of patients with UA/NSTEMI; Initial management of UA/NSTEMI in the emergency department; Pharmacologic treatment of ischemia in UA/NSTEMI; Beta-blockers; Nitrates; Calcium channel blockers; Angiotensin-converting enzyme inhibitors; Morphine; Oxygen; Invasive versus conservative strategy; Antiplatelet therapy in UA/NSTEMI; Aspirin; Clopidogrel; Prasugrel; Glycoprotein IIb/IIIa inhibitors; Anticoagulant therapy in UA/NSTEMI; Unfractionated heparin; Enoxaparin; Direct thrombin inhibitors; Fondaparinux Oral anticoagulation in UA/NSTEMIFibrinolysis in UA/NSTEMI; Early lipid-lowering therapy in patients with UA/NSTEMI; Predischarge noninvasive risk stratification after UA/NSTEMI; Overall management of UA/NSTEMI; References; Chapter 4 ST-segment-elevation myocardial infarction; Introduction; Global treatment goals in STEMI; Prehospital management and triage; Transport decisions; Management prior to reperfusion; Primary reperfusion therapy for STEMI; Fibrinolysis; Combination fibrinolysis; Markers of fibrinolysis effectiveness; Complications of fibrinolysis Primary percutaneous coronary interventionComparison of PCI with fibrinolysis; Timing of primary PCI; PCI following fibrinolytic therapy; Rescue PCI; Facilitated PCI; Routine PCI after successful fibrinolysis; Overall reperfusion strategy; Coronary artery bypass grafting for treatment of STEMI; Adjunctive pharmacologic treatment of STEMI; Antiplatelet agents; Anticoagulation therapy; Other adjunctive therapy; Hospital care following successful reperfusion; References; Chapter 5 Special considerations in acute coronary syndromes; Secondary unstable angina Acute coronary syndrome in patients with diabetes mellitus |
| Record Nr. | UNINA-9910876606703321 |
|
Gelfand Eli V
|
||
| Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley & Sons, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||